| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $39.87 ▲ +1.15% | Yesterday | $39.23 ▼ -0.48% | Tomorrow's Novo Nordisk A/S Common Stock (NVO) setup is anchored to $39.42 and targets $39.87 (+1.15%). The near-term read is upside; watch $40.60 / $38.24 because daily realized volatility is about 5.93%. |
Tomorrow's Novo Nordisk A/S Common Stock (NVO) setup is anchored to $39.42 and targets $39.87 (+1.15%). The near-term read is upside; watch $40.60 / $38.24 because daily realized volatility is about 5.93%. | ||||
| Week | $40.83 ▲ +3.58% | Last Week | $38.83 ▼ -1.50% | The 7-day Novo Nordisk A/S Common Stock model moves from $38.83 to $40.83 (+3.58%). It gives upside momentum context for this stock, so breaks around $40.60 / $38.24 matter more than a single tick. |
The 7-day Novo Nordisk A/S Common Stock model moves from $38.83 to $40.83 (+3.58%). It gives upside momentum context for this stock, so breaks around $40.60 / $38.24 matter more than a single tick. | ||||
| Month | $42.42 ▲ +7.61% | Last Month | $38.16 ▼ -3.20% | The 1-month Novo Nordisk A/S Common Stock target is $42.42 (+7.61%), compared with the live reference near $39.42. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Novo Nordisk A/S Common Stock target is $42.42 (+7.61%), compared with the live reference near $39.42. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $44.81 ▲ +13.67% | Last Year | $37.16 ▼ -5.74% | The 1-year Novo Nordisk A/S Common Stock scenario points to $44.81 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Novo Nordisk A/S Common Stock scenario points to $44.81 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $50.40 ▲ +27.86% | 5 Years Ago | $34.81 ▼ -11.70% | The 5-year Novo Nordisk A/S Common Stock view is $50.40 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Novo Nordisk A/S Common Stock view is $50.40 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $39.42 | Mid |
| Daily Change | -2.57% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $39.42 | Daily Change | -2.57% |
| Market Cap | $176.01B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.